Contrast-enhanced CBCT With C-arm HyperSight Technology
Recruiting
N/A
Interventional Study
Advanced Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- University Health Network, Toronto · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a single-arm prospective, feasibility study evaluating the intravenous contrast-enhanced cone beam computed tomography (IV CBCT) for image guidance during radiotherapy. Patients treated with SFRT will receive IV-contrast enhanced CT and fMRI before treatment for simulation purposes. Additionally, patients will receive mpMRI just before and IV-contrast enhanced CBCT during their second and …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Primary biopsy-proven cancer
* Planning to undergo spatially fractionated radiation therapy
* Able to provide informed consent
* Willingness to participate in follow-up
* ECOG less than or equal to 3
* Normal creatinine (below 109mmol/L), normal eGF
Exclusion Criteria:
* Una…
Contacts